An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.

A man surnamed Zhang from northwest China's Xinjiang Uygur Autonomous Region was diagnosed with maxillary sinus cancer in May, with a 6.2-cm-diameter tumor expanding in his mouth and distorting his ...

This article discusses the roadblocks preventing labs from utilizing transformative technologies and evaluates how ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

According to a 2011–2012 analysis, c aring for children with food allergies cost U.S. families nearly $25 billion annually ... compared to only 7% in the placebo group. This biologic therapy was ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

A Watertown biotech says is received a $112 million investment led by the investment firm that manages the assets of the Novo ...

But most people who buy coverage from HealthCare.gov or a state marketplace don't pay the full monthly cost for health insurance. More than 90% of health insurance plans from HealthCare.gov or state ...

The bioreactors market is expected to grow at 12.6% CAGR from 2024 to 2030. It is expected to reach above USD 24.24 billion by 2030 from USD 10.56 billion in 2023. Get the PDF Sample Copy of this ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

"In this election and especially here in Pennsylvania, we have the opportunity to tell the whole world who we are. We have the chance to say we are going to reject cruelty, vile and vitriol that ...